ClinicalTrials.govpublic full text
Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients
critical limb ischemia (cli), diabetes, mesenchymal stem cells, regenerative therapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 865297
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.